Benjamin RJ. A conceptual framework for managing iTTP. Blood. 2021;137(14):1845-1846.

Page 1846: In reference 9, “Blood. 2021;137(7):969-976” should read “Blood Adv. 2020;4(3):539-545.” In reference 10, “Gosha” should read “Goshua,” and the final published version of the reference [Blood. 2021;137(7):969-976] should be cited instead of the online ahead-of-print version. The corrected references are shown below.

9. Goshua G, Gokhale A, Hendrickson JE, Tormey C, Lee AI. Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(3):539-545.

10. Goshua G, Sinha P, Hendrickson JE, Tormey C, Bendapudi PK, Lee AI. Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood. 2021;137(7):969-976.